CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $28,000 | -84.5% | 10,300 | -60.1% | 0.00% | -100.0% |
| Q1 2021 | $181,000 | -88.4% | 25,807 | -90.4% | 0.00% | -93.3% |
| Q3 2020 | $1,561,000 | +1578.5% | 267,646 | +1735.1% | 0.03% | +400.0% |
| Q1 2020 | $93,000 | -98.0% | 14,585 | -78.9% | 0.01% | -98.4% |
| Q4 2017 | $4,709,000 | +24.1% | 69,240 | +50.3% | 0.39% | +11.2% |
| Q3 2017 | $3,796,000 | -63.4% | 46,064 | -58.4% | 0.35% | -67.5% |
| Q2 2017 | $10,360,000 | +263.9% | 110,657 | +147.5% | 1.07% | +274.7% |
| Q1 2017 | $2,847,000 | +73.8% | 44,718 | +21.3% | 0.28% | +34.4% |
| Q4 2016 | $1,638,000 | -68.9% | 36,874 | -74.8% | 0.21% | -76.3% |
| Q3 2016 | $5,275,000 | +1469.9% | 146,322 | +498.7% | 0.90% | +1094.7% |
| Q2 2016 | $336,000 | +44.2% | 24,440 | +102.1% | 0.08% | -21.1% |
| Q1 2016 | $233,000 | – | 12,096 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |